Allergic disorders: When should you consider immunotherapy?

Rana S. Bonds, J. Andrew Grant, William Calhoun

Research output: Contribution to journalArticle

Abstract

Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergsns once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.

Original languageEnglish (US)
Pages (from-to)405-412
Number of pages8
JournalConsultant
Volume47
Issue number4
StatePublished - Apr 1 2007

Fingerprint

Immunotherapy
Asthma
Immunologic Desensitization
Allergic Conjunctivitis
Venoms
Allergens
Immunoglobulin E
Insects
Appointments and Schedules
Hypersensitivity
Maintenance
Injections
Allergic Rhinitis

Keywords

  • Allergic asthma
  • Allergic rhinitis
  • Immunotherapy
  • Venom allergy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Allergic disorders : When should you consider immunotherapy? / Bonds, Rana S.; Grant, J. Andrew; Calhoun, William.

In: Consultant, Vol. 47, No. 4, 01.04.2007, p. 405-412.

Research output: Contribution to journalArticle

Bonds, RS, Grant, JA & Calhoun, W 2007, 'Allergic disorders: When should you consider immunotherapy?', Consultant, vol. 47, no. 4, pp. 405-412.
Bonds, Rana S. ; Grant, J. Andrew ; Calhoun, William. / Allergic disorders : When should you consider immunotherapy?. In: Consultant. 2007 ; Vol. 47, No. 4. pp. 405-412.
@article{6daa7e3874a749fb97561051fa828a4d,
title = "Allergic disorders: When should you consider immunotherapy?",
abstract = "Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergsns once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.",
keywords = "Allergic asthma, Allergic rhinitis, Immunotherapy, Venom allergy",
author = "Bonds, {Rana S.} and Grant, {J. Andrew} and William Calhoun",
year = "2007",
month = "4",
day = "1",
language = "English (US)",
volume = "47",
pages = "405--412",
journal = "Consultant",
issn = "0010-7069",
publisher = "Cliggott Publishing Co.",
number = "4",

}

TY - JOUR

T1 - Allergic disorders

T2 - When should you consider immunotherapy?

AU - Bonds, Rana S.

AU - Grant, J. Andrew

AU - Calhoun, William

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergsns once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.

AB - Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergsns once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.

KW - Allergic asthma

KW - Allergic rhinitis

KW - Immunotherapy

KW - Venom allergy

UR - http://www.scopus.com/inward/record.url?scp=34247559593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247559593&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34247559593

VL - 47

SP - 405

EP - 412

JO - Consultant

JF - Consultant

SN - 0010-7069

IS - 4

ER -